Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Ter ; 175(2): 112-117, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38571468

RESUMEN

Purpose: Primary central nervous system vasculitis (PCNSV) is a rare inflammatory disease affecting the central nervous system. In some cases, it presents with large, solitary lesion with extensive mass effect that mimic intracranial neoplasms. This condition results in a diagnostic confusion for neuroradiologists because the differentiation is almost impossible on conventional MRI sequences. The aim of this study is to reveal the significance of dynamic susceptibility contrast (DSC) perfusion-weighted imaging in differentiating of tumefactive PCNSV (t-PCNSV) lesions from intracranial neoplasms such as glio-blastomas and metastasis. Methods: In this retrospective study, DSC of 8 patients with biopsy-proven t-PCNSV has been compared with DSC obtained in 10 patients with glioblastoma, 10 patients with metastasis, who underwent surgery and histopathological confirmation. The ratio of relative cerebral blood volume (rrCBV) was calculated by rCBV (lesion) / rCBV (controlateral normal-appearing white matter) in the gadolinium-enhancing solid areas. Results: The mean rrCBV was 0.86±0.7 (range: 0.76-0.98) in the patients with t-PCNSV, 5,16±0.79 in patients with glioblastoma (range: 3.9-6.3), and 4.27±0.73 (range: 2.8-5.3) in patients with metastases. Conclusion: DSC-PWI seems to be useful in the diagnostic work-up of t-PCSNVs. A low rrCBV, i.e. a rCBV similar or lower to that of the contralateral normal white matter, seems to be consistent with the possibility of t-PCSNV.


Asunto(s)
Neoplasias Encefálicas , Glioblastoma , Vasculitis del Sistema Nervioso Central , Humanos , Glioblastoma/irrigación sanguínea , Glioblastoma/patología , Estudios Retrospectivos , Imagen por Resonancia Magnética/métodos , Neoplasias Encefálicas/diagnóstico por imagen , Vasculitis del Sistema Nervioso Central/diagnóstico por imagen , Perfusión
2.
Oncogene ; 26(16): 2290-8, 2007 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-17043652

RESUMEN

E-cadherin-mediated cell-cell adhesion is frequently lost during the development of malignant epithelial cancers. Employing a transgenic mouse model of beta-cell carcinogenesis (Rip1Tag2) we have previously shown that the loss of E-cadherin is a rate-limiting step in the progression from adenoma to carcinoma. However, the mere loss of cell adhesion may not be sufficient and additional signals are required to cause tumor cells to permeate the basal membrane and to invade surrounding tissue. Besides being an important component of the E-cadherin cell-adhesion complex, beta-catenin plays a critical role in canonical Wnt signaling. We report here that beta-catenin-mediated Wnt signaling does not contribute to tumor progression in Rip1Tag2 mice. E-cadherin downregulates beta-catenin/Tcf-mediated transcriptional activity by sequestrating beta-catenin into E-cadherin cell-adhesion complexes even in the presence of activated Wnt signaling. Upon loss of E-cadherin expression, beta-catenin is degraded and Tcf/beta-catenin-mediated transcriptional activity is not induced. Moreover, forced expression of constitutive-active beta-catenin or genetic ablation of Tcf/beta-catenin transcriptional activity in tumor cells of Rip1Tag2 transgenic mice does not affect tumor progression. Together, the data indicate that signals other than beta-catenin/Tcf-mediated Wnt signaling are induced by the loss of E-cadherin during tumor progression in Rip1Tag2 transgenic mice.


Asunto(s)
Adenoma/patología , Cadherinas/genética , Linfoma/patología , Factores de Transcripción TCF/fisiología , Proteínas Wnt/fisiología , beta Catenina/fisiología , Animales , Cadherinas/deficiencia , Cadherinas/fisiología , Cartilla de ADN , Progresión de la Enfermedad , Regulación Neoplásica de la Expresión Génica , Humanos , Insulinoma , Ratones , Ratones Transgénicos , Invasividad Neoplásica , Neoplasias Pancreáticas , Reacción en Cadena de la Polimerasa , Transcripción Genética
3.
Minerva Ginecol ; 54(2): 145-50, 2002 Apr.
Artículo en Italiano | MEDLINE | ID: mdl-12032452

RESUMEN

Maternal endocrine disorders can have detrimental effects on the fetus and the pregnancy can affect the course of a pre-exisiting endocrinopathy or induce the onset of one of these disorders. Therapies for endocrine disorders are not always safe to administer during pregnancy. Before administering any therapy to the mother, the effects on the fetus, the degree of placental trespassing as well as the potential damaging effects must be assessed. An accurate evaluation of the risks/benefits of any drug to be used on the mother is needed, assessing above all a potential theratogenic effect. In this review, the incidence of the main endocrine disorders, their evolution during pregnancy, their effects on mothers and fetuses and new acquisition on the treatment during pregnancy are discussed.


Asunto(s)
Anomalías Inducidas por Medicamentos/etiología , Enfermedades del Sistema Endocrino/tratamiento farmacológico , Feto/efectos de los fármacos , Hormonas/uso terapéutico , Complicaciones del Embarazo/tratamiento farmacológico , Acromegalia/tratamiento farmacológico , Enfermedad de Addison/tratamiento farmacológico , Adulto , Niño , Síndrome de Cushing/tratamiento farmacológico , Diabetes Insípida/tratamiento farmacológico , Femenino , Hormonas/efectos adversos , Humanos , Hipercalcemia/tratamiento farmacológico , Hiperparatiroidismo/tratamiento farmacológico , Hipertiroidismo/tratamiento farmacológico , Hipoparatiroidismo/tratamiento farmacológico , Hipotiroidismo/tratamiento farmacológico , Recién Nacido , Neoplasias Hipofisarias/tratamiento farmacológico , Neoplasias Hipofisarias/cirugía , Embarazo , Complicaciones Neoplásicas del Embarazo/tratamiento farmacológico , Complicaciones Neoplásicas del Embarazo/cirugía , Prolactinoma/tratamiento farmacológico , Prolactinoma/cirugía , Medición de Riesgo
4.
Neuroradiology ; 41(4): 275-8, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10344514

RESUMEN

A 62-year-old diabetic woman developed permanent neurological deficits in the legs following spinal anaesthesia. MRI showed oedema in the spinal cord and a small intramedullary focus of signal void at the T10 level, with negative density at CT. Intramedullary gas bubbles have not been reported previously among the possible neurological complications of spinal anaesthesia; a combined ischaemic/embolic mechanism is hypothesised.


Asunto(s)
Anestesia Raquidea/efectos adversos , Embolia Aérea/etiología , Hemiplejía/etiología , Imagen por Resonancia Magnética , Trastornos de la Sensación/etiología , Enfermedades de la Médula Espinal/etiología , Tomografía Computarizada por Rayos X , Complicaciones de la Diabetes , Edema/diagnóstico , Edema/diagnóstico por imagen , Edema/etiología , Electromiografía , Embolia Aérea/diagnóstico , Embolia Aérea/diagnóstico por imagen , Femenino , Estudios de Seguimiento , Humanos , Hipoestesia/etiología , Isquemia/diagnóstico , Isquemia/diagnóstico por imagen , Isquemia/etiología , Pierna/inervación , Persona de Mediana Edad , Debilidad Muscular/etiología , Reflejo Anormal , Médula Espinal/irrigación sanguínea , Enfermedades de la Médula Espinal/diagnóstico , Enfermedades de la Médula Espinal/diagnóstico por imagen
6.
Minerva Ginecol ; 50(1-2): 43-9, 1998.
Artículo en Italiano | MEDLINE | ID: mdl-9577155

RESUMEN

In this review are reported the data regarding medical and gynecological responsibility in case of underestimation of ovarian pathology compared to epidemiological data. It is important to recognize the characteristics of the symptomatology, in general very mild, and the diagnostic tests suitable to detect ovarian masses. Four steps in the management of ovarian masses which may generate errors in the diagnostic and therapeutical process are stressed: the clinical diagnosis phase, the surgical phase, the management of borderline tumors, and the follow-up. It is also highlighted the importance of the concept of the "delay" in the medical action, both diagnostic and therapeutical, and an involvement of the Public Health Service, both in the prevention and the treatment of ovarian lesions, is ipothesized.


Asunto(s)
Legislación Médica , Neoplasias Ováricas/diagnóstico , Adulto , Errores Diagnósticos , Femenino , Humanos , Italia , Persona de Mediana Edad , Neoplasias Ováricas/cirugía , Ovariectomía , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA